Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Extensive global movement of multidrug-resistant M. tuberculosis strains revealed by whole-genome analysis.

Cohen KA, Manson AL, Abeel T, Desjardins CA, Chapman SB, Hoffner S, Birren BW, Earl AM.

Thorax. 2019 May 2. pii: thoraxjnl-2018-211616. doi: 10.1136/thoraxjnl-2018-211616. [Epub ahead of print]

2.

Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities.

Story-Roller E, Maggioncalda EC, Cohen KA, Lamichhane G.

Front Microbiol. 2018 Sep 25;9:2273. doi: 10.3389/fmicb.2018.02273. eCollection 2018. Review.

3.

Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.

Kumar P, Chauhan V, Silva JRA, Lameira J, d'Andrea FB, Li SG, Ginell SL, Freundlich JS, Alves CN, Bailey S, Cohen KA, Lamichhane G.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00866-17. doi: 10.1128/AAC.00866-17. Print 2017 Oct.

4.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.

Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16.

5.

Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.

Cohen KA, El-Hay T, Wyres KL, Weissbrod O, Munsamy V, Yanover C, Aharonov R, Shaham O, Conway TC, Goldschmidt Y, Bishai WR, Pym AS.

EBioMedicine. 2016 Jul;9:170-179. doi: 10.1016/j.ebiom.2016.05.041. Epub 2016 Jun 1.

6.

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.

Desjardins CA, Cohen KA, Munsamy V, Abeel T, Maharaj K, Walker BJ, Shea TP, Almeida DV, Manson AL, Salazar A, Padayatchi N, O'Donnell MR, Mlisana KP, Wortman J, Birren BW, Grosset J, Earl AM, Pym AS.

Nat Genet. 2016 May;48(5):544-51. doi: 10.1038/ng.3548. Epub 2016 Apr 11.

7.

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM.

PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.

8.

Molecular Basis of Drug Resistance in Mycobacterium tuberculosis.

Cohen KA, Bishai WR, Pym AS.

Microbiol Spectr. 2014 Jun;2(3). doi: 10.1128/microbiolspec.MGM2-0036-2013. Review.

PMID:
26103975
9.

Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.

Gupta S, Cohen KA, Winglee K, Maiga M, Diarra B, Bishai WR.

Antimicrob Agents Chemother. 2014;58(1):574-6. doi: 10.1128/AAC.01462-13. Epub 2013 Oct 14.

10.

Rising to the challenge: new therapies for tuberculosis.

Wong EB, Cohen KA, Bishai WR.

Trends Microbiol. 2013 Sep;21(9):493-501. doi: 10.1016/j.tim.2013.05.002. Epub 2013 Jun 11. Review.

11.

Predictors of obesity in Michigan Operating Engineers.

Duffy SA, Cohen KA, Choi SH, McCullagh MC, Noonan D.

J Community Health. 2012 Jun;37(3):619-25. doi: 10.1007/s10900-011-9492-1.

12.

Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance.

Cohen KA, Lautenbach E, Weiner MG, Synnestvedt M, Gasink LB.

Infect Control Hosp Epidemiol. 2008 Oct;29(10):975-7. doi: 10.1086/590666.

PMID:
18808343
13.
14.

Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells.

Westcott MM, Abi-Habib RJ, Cohen KA, Willingham MC, Liu S, Bugge TH, Leppla SH, Frankel AE.

Mol Cancer Ther. 2004 Dec;3(12):1681-9.

15.

Safety evaluation of DT388IL3, a diphtheria toxin/interleukin 3 fusion protein, in the cynomolgus monkey.

Cohen KA, Liu TF, Cline JM, Wagner JD, Hall PD, Frankel AE.

Cancer Immunol Immunother. 2005 Aug;54(8):799-806. Epub 2004 Dec 22.

PMID:
15614527
16.

Combined pars plana vitrectomy and lens management in complex vitreoretinal disease.

Chaudhry NA, Cohen KA, Flynn HW Jr, Murray TG.

Semin Ophthalmol. 2003 Sep;18(3):132-41. Review.

PMID:
15513474
17.
18.

Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.

Urieto JO, Liu T, Black JH, Cohen KA, Hall PD, Willingham MC, Pennell LK, Hogge DE, Kreitman RJ, Frankel AE.

Protein Expr Purif. 2004 Jan;33(1):123-33.

PMID:
14680969
19.

Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture.

Liu TF, Cohen KA, Willingham MC, Tatter SB, Puri RK, Frankel AE.

J Neurooncol. 2003 Oct;65(1):77-85.

PMID:
14649887
20.

Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.

Liu TF, Willingham MC, Tatter SB, Cohen KA, Lowe AC, Thorburn A, Frankel AE.

Bioconjug Chem. 2003 Nov-Dec;14(6):1107-14.

PMID:
14624623
21.

A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells.

Liu TF, Cohen KA, Ramage JG, Willingham MC, Thorburn AM, Frankel AE.

Cancer Res. 2003 Apr 15;63(8):1834-7.

22.

DAB389EGF fusion protein therapy of refractory glioblastoma multiforme.

Cohen KA, Liu T, Bissonette R, Puri RK, Frankel AE.

Curr Pharm Biotechnol. 2003 Feb;4(1):39-49. Review.

PMID:
12570681
23.

High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus.

Palladino DE, Hopkins JL, Ingraham RH, Warren TC, Kapadia SR, Van Moffaert GJ, Grob PM, Stevenson JM, Cohen KA.

J Chromatogr A. 1994 Jul 29;676(1):99-112.

PMID:
7522840
24.

Rapid, sensitive and efficient HPLC assays for HIV-1 proteinase.

Betageri R, Hopkins JL, Thibeault D, Emmanuel MJ, Chow GC, Skoog MT, de Dreu P, Cohen KA.

J Biochem Biophys Methods. 1993 Oct;27(3):191-7.

PMID:
8258639
25.
26.

Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.

Grob PM, Wu JC, Cohen KA, Ingraham RH, Shih CK, Hargrave KD, McTague TL, Merluzzi VJ.

AIDS Res Hum Retroviruses. 1992 Feb;8(2):145-52. Review.

PMID:
1371691
27.

Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay.

Hopkins JL, Betageri R, Cohen KA, Emmanuel MJ, Joseph CR, Bax PM, Pallai PV, Skoog MT.

J Biochem Biophys Methods. 1991 Sep;23(2):107-13.

PMID:
1658106
28.

Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.

Cohen KA, Hopkins J, Ingraham RH, Pargellis C, Wu JC, Palladino DE, Kinkade P, Warren TC, Rogers S, Adams J, et al.

J Biol Chem. 1991 Aug 5;266(22):14670-4.

29.

Cleavage of synthetic peptides by purified poliovirus 3C proteinase.

Pallai PV, Burkhardt F, Skoog M, Schreiner K, Bax P, Cohen KA, Hansen G, Palladino DE, Harris KS, Nicklin MJ, et al.

J Biol Chem. 1989 Jun 15;264(17):9738-41.

30.

Pharmaceuticals. Tracking down an unidentified trace level constituent.

Hopkins JL, Cohen KA, Hatch FW, Pitner TP, Stevenson JM, Hess FK.

Anal Chem. 1987 Jun 1;59(11):784A-790A. No abstract available.

PMID:
3619039
31.

Connective tissue diseases and bovine collagen implants.

McCoy JP Jr, Waldinger TP, Cohen KA, Schade W, Siegle R, Hamilton TA, Swanson NA.

J Am Acad Dermatol. 1987 Feb;16(2 Pt 1):315-8.

PMID:
3819066
32.

Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects.

Ziboh VA, Cohen KA, Ellis CN, Miller C, Hamilton TA, Kragballe K, Hydrick CR, Voorhees JJ.

Arch Dermatol. 1986 Nov;122(11):1277-82.

PMID:
3022655
33.

Increased muscle tone during etretinate therapy.

Ellis CN, Gilbert M, Cohen KA, Albers JW, Ball RD, Albin RL, Silverman A, Voorhees JJ.

J Am Acad Dermatol. 1986 May;14(5 Pt 2):907-9.

PMID:
3711400
34.

Mobile-phase and temperature effects in the reversed phase chromatographic separation of proteins.

Cohen KA, Schellenberg K, Benedek K, Karger BL, Grego B, Hearn MT.

Anal Biochem. 1984 Jul;140(1):223-35.

PMID:
6486409

Supplemental Content

Loading ...
Support Center